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INTRODUCTION (3,408)
Immediately before cell divisions, chromatin that resides in the nucleus is converted into a set of rodshaped structures to support their faithful segregation into daughter cells. The condensin complexes play a central role in this process, known as mitotic chromosome assembly or condensation, and also participate in diverse chromosome functions such as gene regulation, recombination and repair (Uhlmann,, 2016; Hirano, 2016) . Moreover, hypomorphic mutations in the genes encoding condensin subunits have been implicated in the human disease microcephaly (Martin et al., 2016) . Many eukaryotes have two different types of condensin complexes, namely, condensins I and II. Condensin I, for example, consists of a pair of SMC (structural maintenance of chromosomes) ATPase subunits (SMC2 and SMC4) and three non-SMC regulatory subunits (CAP-D2, -G and -H). SMC2 and SMC4 dimerize through their hinge domains to form a V-shaped heterodimer, and CAP-H, which belongs to the kleisin family of proteins, bridges SMC head domains through its C-and N-terminal regions. CAP-D2 and -G, both of which are composed of arrays of short amphiphilic helices, known as HEAT repeats, bind to the central region of CAP-H (Onn et al., 2007) (Yoshimura & Hirano, 2016) . Although many if not all prokaryotic species have a primitive type of condensin composed of an SMC homodimer and two other regulatory subunits including a kleisin subunit, the HEAT repeat subunits are unique to eukaryotic condensins, and not found in prokaryotic condensins.
Biochemical studies using purified condensin I holocomplexes identified several ATP-dependent activities in vitro, such as positive supercoiling of DNA (Hagstrom et al., 2002; Kimura & Hirano, 1997; St-Pierre et al., 2009) , DNA compaction (Strick et al., 2004) , translocation along dsDNA (Terakawa et al., 2017) , and DNA loop extrusion (Ganji et al., 2018) . Mechanistically how these activities are supported by condensin I remains poorly understood. In fact, condensin I has the capacity to interact with DNA in many different ways. For instance, like cohesin and prokaryotic SMC complexes, it encircles doublestranded DNA (dsDNA) within its tripartite ring composed of the SMC dimer and kleisin (Cuylen et al., 2011; Ivanov & Nasmyth, 2005; Wilhelm et al., 2015) . It has also been shown that a mouse SMC2-SMC4 hinge domain binds single-stranded DNA (ssDNA), but not dsDNA (Griese et al., 2010) , whereas a budding yeast non-SMC subcomplex composed of YCG1/CAP-G, YCS4/CAP-D2, and BRN1/ CAP-H binds dsDNA, but not ssDNA (Piazza et al., 2014) . A recent study reported the crystal structure of a budding yeast non-SMC subcomplex consisting of YCG1 and BRN1 bound to dsDNA (Kschonsak et al., 2017) . Another study using Xenopus egg cell-free extracts showed that the pair of the HEAT repeat subunits has a critical role in dynamic assembly of mitotic chromosome axes (Kinoshita et al., 2015) .
In the current study, we have determined the crystal structure of a human subcomplex composed of CAP-G bound by a short fragment of CAP-H. The structure established molecular interactions between human CAP-G and CAP-H, and implicated a role for these interactions in the ability of condensin I to support mitotic chromosome assembly. Furthermore, the human CAP-G-H subcomplex bound both dsDNA and ssDNA, implicating a potential, functional divergence of the eukaryotic condensin I complex.
RESULTS AND DISCUSSION (18,794)

Structure of a human CAP-G-H subcomplex
The consensus sequence of HEAT repeats at the primary structure level is not tight. The original report by Neuwald and Hirano (2000) had assigned nine HEAT repeats in vertebrate CAP-G, whereas a subsequent re-assignment by Yoshimura and Hirano (2016) had identified 19 HEAT repeats that span along the nearentire length of human CAP-G (hCAP-G). Furthermore, the secondary structural prediction server PrDOS (Ishida & Kinoshita, 2007) predicted that hCAP-G has two disordered, non-HEAT regions in its central (amino-acid residues 479-553) and C-terminal (901-1015) sequences ( Fig. 1A, upper) . On the other hand, human CAP-H (hCAP-H) had five regions that are conserved among its orthologs among eukaryotic species (motifs I-V) ( Fig. 1A, lower) . Previous biochemical study had shown that the N-terminal and Cterminal halves of hCAP-H bind to hCAP-D2 and hCAP-G, respectively (Onn et al., 2007) . Because the most C-terminally located motif V was predicted to bind to SMC2 (Haering et al., 2004) , we thought that motif IV (residues 461-503) might be responsible for binding to hCAP-G. With these pieces of information in our hand, we aimed to express and purify hCAP-G complexed with a fragment of hCAP-H.
We found that the entire HEAT domain of hCAP-G lacking the internal disordered region (residues 1-478, 554-900) and a fragment of hCAP-H containing motif IV (residues 460-515) could be co-expressed and co-purified. This hCAP-G-H subcomplex was successfully crystalized and its structure was determined at 3.0 Å resolution ( Table 1) . Two molecules of hCAP-G-H subcomplex are present in the crystallographic asymmetric unit (Fig. EV2A) . Their structures are essentially identical, but a 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid (HEPES) is bound to only one of the two molecules. In the current report, we describe the HEPES-bound hCAP-G-H subcomplex (a, b-molecules) as a representative structure ( Fig.   1B ) in the current report.
Consistent with the recent assignment based on its amino-acid sequence (Yoshimura & Hirano, 2016) , hCAP-G displays a "harp-shaped" structure composed of 19 HEAT repeats (H1-H19), in which H12 and H15 have disordered loops (residues 479-553 and 661-691, respectively)( Fig. 1, B-C; Fig.  EV1A; Fig. EV2B ). hCAP-H, which comprises four α-helices (α2, α3', α3", and α4), binds to the concave surfaces of hCAP-G ( Fig. 1B; Fig. EV1B ). This overall structure in which a kleisin fragment binds to the concave surfaces of a harp-shaped HEAT repeat domain is highly reminiscent of other cohesin subunits and its regulators (Hara et al., 2014; Kikuchi et al., 2016; Ouyang et al., 2016) as well as budding and fission yeast condensin subunits (YCG1-BRN1 and CND3/CAP-G-CND2/CAP-H; Kschonsak et al., 2017) . It should be noted that hCAP-G used in this study shares only 16% and 21% amino-acid identities to YCG1 and CND3, respectively, and that the hCAP-H fragment bound to hCAP-G shares only 25% and 29% identities to BRN1 and CND2, respectively. Despite the great divergence in their amino-acid sequences, two basic residues (K60, R848) located at the N-and C-terminal lobes of hCAP-G, which corresponds to K70 (YC1) and R849 (YC2) of YCG1, respectively, are conserved well ( Fig. EV1A) . Likewise, four basic residues (R435, R437, K456, and K457) of hCAP-H, which corresponds to K409 (BC1), R411 (BC1), K456 (BC2), and K457 (BC2) of BRN1, respectively, are also conserved ( Fig. EV1B) . Kschonsak et al. (2017) has recently shown that the corresponding amino-acid residues of YCG1-BRN1 contribute to dsDNA binding, strongly suggesting that the hCAP-G-H subcomplex also uses these residues to bind to dsDNA (see below).
We next performed superimpositions between the hCAP-G-H subcomplex and its budding yeast counterpart YCG1-BRN1 by using PyMoL (http://www.pymol.org/). Structural alignment between the two subcomplexes ( Fig. 1D , orange and blue) shows a root mean square deviation (RMSD) value of 4.206 Å for 3,956 superimposable atoms. Structural alignment between hCAP-G-H and its fission yeast counterpart CND3-CND2 (Fig. 1D, orange and green) shows an RMSD value of 5.419 Å for 4,044 superimposable atoms. These superimpositions indicate that the overall structure of hCAP-G-H is basically identical to the structures of its yeast counterparts. There are nonetheless several notable differences between the human and yeast structures. First, some secondary structures of hCAP-G-H subcomplex are different from those of the yeast counterparts. The H12 loop is a common disordered loop also found in the yeast counterparts, but the H15 disordered loop present in hCAP-G is missing in its yeast counterparts ( Fig. 1, B-C; Fig. EV1A ). The hCAP-H sequence (residues 499-503), which corresponds to the buckle region of BRN1 (residues 498-504) and CND2 (residues 519-523) critical for the "safety-belt" mechanism (Kschonsak et al., 2017) , is also disordered in our hCAP-G-H structure. (Fig.   EV1A) . Notably, the α3 helix of BRN1 is split into two helices (the α3' and α3" helices) in hCAP-H, producing a disordered loop that connects the two helices ( Fig. EV1B) . Overall, the hCAP-G-H subcomplex is structurally more flexible compared with the YCG1-BRN1 subcomplex. Second, hCAP-H is more loosely bound with hCAP-G than the YCG1-BRN1 subcomplex. In fact, the distance between the NH2 of R257 and the CG2 of V754 of hCAP-G, located at H7 and H16, respectively, is 17.06 Å ( Fig.   2A ), whereas the corresponding distance between the NH2 of R287 and the CD2 of F749 of YCG1 is 6.25 Å (Fig. EV3A) . The distance between the NZ of K154 and NZ of K889 of hCAP-G, located at H4 and H19, respectively, is 35.29 Å ( Fig. 2A) , whereas the corresponding distance between the NH1 of R170 and NZ of K895 of YCG1 is 23.02 Å (Fig. EV3A) . These differences in the structural flexibility allow us to speculate that our hCAP-G-H structure represents an "open conformation" before binding to DNA, whereas the structure of its yeast counterpart represents a "closed conformation" after capturing dsDNA.
Structural details of the interaction between hCAP-G and hCAP-H
hCAP-H interacts extensively with the concave surface of hCAP-G at four major sites ( Fig. 2A) , whereas YCG1 interacts with BRN1 at five major sites (Kschonsak et al., 2017;  Fig. EV3A ). At site I, a pocket comprised of residues located at H1 (K11, F14, R15, and Q18) and H2 (Y51, Y54, V55, A64, V65, and V68) of hCAP-G accommodate I461 and F463 positioned at the N-terminal loop of hCAP-H through van der Waals contacts ( Fig. 2B) . F469, Y472, and F473 within the α2 helix of hCAP-H make mainly hydrophobic interactions with residues located at H2 (K53, M56, V57) and H3 (F102, S106, S111, and V114) of hCAP-G. In the YCG1-BRN1 subcomplex, I461, F463, E471, V474, and F475 within the Nterminal loop and the α2 helix of BRN1 form conserved hydrophobic interactions with YCG1, although van der Waals interactions also form between E460 of BRN1 and Q25 of YCG1, F464 of BRN1 and a pocket comprising F14, N15, A18, E19, and Q22 of YCG1, and T466 and N468 of BRN1 and F14 and K64 positioned at the edge of a conserved pocket of YCG1 ( Fig. EV3B) .
At site II, hCAP-H interacts with hCAP-G by van der Waals forces. K475, T476, A479, T480, and I481 of CAP-H are accommodated in a shallow pocket, where is composed of E108, N110, R115, R150, K152, K154, and R159 positioned at the H3 and H4 domains of CAP-G ( Fig. 2C) . At site II of the YCG1-BRN1 subcomplex, some residues (K478, T481, K482, I483, D484, and M485) of BRN1 also interacts with YCG1 by van der Waals interactions. Especially, I483 and M485 of BRN1 are accommodated in two deep pockets, where are composed of E127, P129, R134, R166, Y168, D169, R170, and P218 positioned at the corresponding domains of YCG1 (Fig. EV3C) . The site II interactions in both hCAP-G-H and YCG1-BRN1 primarily involve hydrophobic interactions, but the depths of their interaction pockets are substantially different: hCAP-G recognizes the small side chain of hCAP-H, whereas YCG1 could recognizes bulky side chains of BRN1.
At site III, T495 within the α3" helix of hCAP-H is accommodated in a shallow pocket, composed of E188, N189, R196, R216, K218, and V220 positioned at the H5 and H6 domains of hCAP-G ( Fig. 2D) . A pocket comprised of residues located at H6 (V220 and R225) and H7 (R257) of hCAP-G accommodates L497 positioned at the C-terminal loop of hCAP-H through van der Waals contacts.
Notably, W492 in the α3" helix forms a cation-π interaction with R493 on the same helix. This interaction may stabilize the binding of W492 of hCAP-H to E188 of hCAP-G mediated by van der Waals forces. At site III of the YCG1-BRN1 subcomplex, YCG1 interacts with BRN1 by van der Waals interactions. R490 of BRN1 forms a cation-π interaction with Y168 of YCG1, and Y496 of BRN1 forms a π-π interaction with P218 of YCG1 ( Fig. EV3D) . K491, H495, and L497 of BRN1 are accommodated in an elongated cleft, where is composed of Y168, N216, P218, R223, E242, R243, R245, and V247 positioned at the H4, H5 and H6 domains of YCG1. Site III of the YCG1-BRN1 subcomplex includes deeper clefts than that of hCAP-G, allowing YCG1 to be able to bind bulky residues of BRN1. Differences of site III could explain why amino acid sequences between hCAP-H and BRN1 are not conserved well.
At site IV, N504, V505, L508, and V509 within the α4 helix of hCAP-H are accommodated in a pocket, composed of M650, E713, K717, F720, V754, F755, V758, and F759 located at the H14, H15, and H16 domains of hCAP-G ( Fig. 2E) . Especially, the conserved L508 of hCAP-H contributes to anchor the α4 helix to a hydrophobic cleft. Five residues (L511, H512, L513, K514, and P515) located at the Cterminal loop of hCAP-H are also accommodated in an elongated cleft, composed of Y565, K569, L606, C610, L613, K643, and A644 located at the H12, H13, and H14 domains of hCAP-G. H512 and L513 of hCAP-H look like "the plug", which puts in the outlet formed by a cleft of hCAP-G. I509, F513, and I514 of BRN1 corresponding to L508, H512, and L513 of hCAP-H also work as a fine tuner and the plug for hydrophobic interactions with YCG1, respectively ( Fig. EV3F) . At site IV, there are also notable hydrogen bonds formed between L511 and H512 of hCAP-H and D647 of hCAP-G ( Fig. 3B) . D647 is an acidic residue broadly conserved among the CAP-G/YCG1 orthologs ( Fig. EV1A) . Interestingly, an aspartate side chain that makes hydrogen bonds with two backbone amides of residues in a pocket is commonly found in the prefusion state of hemagglutinin (HA) of the influenza virus (Ivanovic, Choi, Whelan, van Oijen, & Harrison, 2013) and a binding hotspot between cohesin's HEAT repeat subunit SA2 and kleisin subunit Scc1 (Hara et al., 2014) .
The YCG1-BRN1 subcomplex has an additional HEAT-kleisin interaction site, site III' (Fig.   EV3E ). At site III', L498, P499, D501, F502, and F504 of BRN1 interact with a crack between two cliffs formed by R252, R245, V247, R287, E708, E741, A742, Q745, A746, F749, and E741 positioned at the H6, H7, and H16 domains of YCG1 ( Fig. EV3E) . Although no interactions corresponding to site III' are found in the hCAP-G-H subcomplex, F501 and Y503 of hCAP-H corresponding to F502 and F504 of BRN1 are highly conserved among eukaryotic species. It is therefore possible that the hCAP-G-H subcomplex undergoes conformational changes (from an open form to a closed form) upon binding to dsDNA, forming site III' interactions found in the YCG1-BRN1 subcomplex.
Identification of residues critical for the interaction between hCAP-G and hCAP-H
To identify residues critical for the interaction between hCAP-G and hCAP-H, we designed six mutants that target conserved, surface-exposed residues at the hCAP-G-H interface, and the amount of hCAP-H fragment that co-purified with immobilized His 6 -tagged hCAP-G was evaluated (Fig. 3, A & C) . As expected, three Gln substitutions (3Q) of F463, F469, and F473 of hCAP-H positioned at site I greatly impaired the interaction between hCAP-G and hCAP-H (Fig. 3C, lanes 2 and 3) . Three Ala substitutions (3A) of the same residues also diminished the interaction, suggesting that van der Waals interactions formed by these aromatic residues of CAP-H are crucial for its interaction with hCAP-G (Fig. 3C, lane 5) .
More interestingly, additional Gln or Ala substitutions (5Q or 5A) of F501 and Y503 of hCAP-H positioned at site III' did not further impaired its interaction with hCAP-G (Fig. 3C, lanes 4 and 6) .
These results suggest that F501 and Y503 are not directly involved in hCAP-G-H subcomplex formation, but may be required for the stabilization of a closed conformation after dsDNA binding. A Lys substitution of D647 of hCAP-G positioned at site IV (D647K) decreased its interaction with hCAP-H, suggesting that D647-mediated hydrogen bonds with L511 and H512 of hCAP-H are crucial for its interaction with hCAP-G at site IV ( Fig. 3B; Fig. 3C, lane 7) . We also found that deletion of a Cterminal region of hCAP-H (506-514 residues) also reduced its interaction with hCAP-G ( Fig. 3C, lanes   9 and 10) , supporting the idea that plug-outlet interactions formed by the site IV are critical for hCAP-G-H subcomplex formation, just like site I.
The interaction between hCAP-G and hCAP-H is essential for proper chromosome assembly mediated by condensin I in Xenopus egg extracts
To test whether the interaction between hCAP-G and hCAP-H is indeed essential for the function of condensin I, we introduced the motif IV quintuple mutations (F463Q, F469Q, F473Q, F501Q, Y503Q; designated IV-5Q) described above into the context of full-length, holocomplexes (Fig. 3A) . By using the baculovirus expression system described previously (Kinoshita et al., 2015) , we co-expressed the five subunits of mammalian condensin I containing either the wild-type or mutant form of hCAP-H in insect cells. An equal level of expression of the five subunits in the two samples was confirmed by immunoblotting against total lysates (Fig. 4A) . Both lysates were then subjected to affinity-purification using glutathione-agarose beads (Note that the SMC4 subunit was GST-tagged), followed by proteolytic cleavage of the GST moiety. Although wild-type hCAP-G was successfully co-purified along with the other four subunits, the IV-5Q mutant form of hCAP-G was almost completely missing from the purified fraction (Fig. 4B) . The complexes purified from the wild-type and mutant lysates were then added back into Xenopus egg extracts depleted of endogenous condensins (Kinoshita et al., 2015) . We found that, although the holocomplex purified from the wild-type lysate produced normal chromosomes (Fig. 4C, top panels), the complex purified from the mutant lysate failed to do so, making abnormal chromosomes with fuzzy surfaces and thin axes ( Fig. 4C, middle panels) . The abnormal structure was highly reminiscent of those produced by the tetrameric mutant complex that lacks the hCAP-G subunit (i.e., G)
we reported previously (Fig. 4C, bottom panels) . These results strongly suggest that the IV-5Q mutations disrupt both physical and functional interactions between hCAP-G and hCAP-H, resulting in the formation of a tetrameric mutant complex that is equivalent to the G complex. Kschonsak et al. (2017) reported the structure of a YCG1-BRN1-dsDNA ternary complex. Despite numerous trials, however, we could not get any crystals of the corresponding ternary complex using hCAP-G and hCAP-H. To test whether our hCAP-G-H subcomplex has the ability to interact with DNA, we performed electrophoretic mobility shift assay (EMSA) using a blunt-ended dsDNA probe and a ssDNA probe. The result clearly showed that the hCAP-G-H subcomplex interacts not only with dsDNA ( Fig. 5, A & B, lanes 1-4) but also with ssDNA ( Fig. 5C, lanes 1-4) . To clarify the crucial residues that interacted with DNA, we mapped potential DNA-binding residues on hCAP-G-H subcomplex using structural information from the YCG1-BRN1-dsDNA ternary complex (Fig. 5D) . It was estimated that the DNA-binding interface of the hCAP-G-H subcomplex is basically similar to that of its budding yeast counterpart. We picked up two positively charged residues (K60 and R848), which correspond to the DNA-binding residues of YCG1 (YC1/2), and constructed a K60D/R848E double mutant. The K60D/R848E double mutation greatly impaired the binding affinities to both dsDNA and ssDNA (Fig. 5,   A & B-C, lanes 5-8) . The results suggested that dsDNA and ssDNA binding interfaces are overlapped, and that the N-and C-terminal HEAT-repeat domains of hCAP-G are likely to be required for binding to both DNA substrates. Next, we mutated R168 of hCAP-G, a residue that is important for HEPES binding ( Fig. 5E) and potentially confers DNA binding as well. We found that a R168E mutant reduced, but not completely eliminated, the affinities for both dsDNA and ssDNA (Fig. 5, A & B-C, lanes 9-12) . Because the small concave surface containing R168 has no enough space to accommodate dsDNA, we speculate that it may adapt open-mouth structure to grab ds DNA. Alternatively, a conformational change of this surface could indirectly affect the DNA binding domain constituted by K60 and R848.
Identification of DNA-binding site in the hCAP-G-H subcomplex
In this study, we have determined the crystal structure of a hCAP-G-H subcomplex, in which the kleisin subunit hCAP-H is more loosely bound to the HEAT subunit hCAP-G, compared with the yeast YCG1-BRN1 complex. We have also demonstrated the structural basis of the interaction between hCAP-G and hCAP-H, whereby hCAP-H binds to hCAP-G with two conserved N-and C-terminal concave surfaces. Despite their great sequence divergences, the human and yeast structures are surprisingly similar to each other, implicating that the basic mechanisms of condensin-mediated chromosome condensation must be widely conserved among eukaryotic species with large and small chromosomes. Our functional assay employing Xenopus egg extracts has convincingly shown that the hCAP-G-H interaction is indeed essential for proper mitotic chromosome assembly. It should be noted that the two different mutant complexes lacking hCAP-G (IV-5Q and G) still retain the ability to be loaded onto chromosomes in our cell-free assay, a result contrary to the prediction from a previous study (Kschonsak et al., 2017) . On the other hand, the ability of the hCAP-G-H subcomplex to interact with ssDNA, which had not been shown for its yeast counterparts, could be related with the finding that condensin binds ssDNA segments in transcribing regions to regenerate dsDNA (Sutani et al., 2015) . It will be very important in the future to further clarify the similarities and detailed differences in the structure and function of this fundamental chromosome organizing machine among different eukaryotic species.
MATERIALS AND METHODS
Protein production and purification
cDNAs corresponding to hCAP-G (amino-acid residues 1-900) and hCAP-H (amino-acid residues 460-515) were cloned into BamHI-HindIII and NdeI-XhoI sites, respectively, of a pETDuet-1 vector (Novagen). Based on the result of a secondary structural prediction, we deleted a putative disordered region of CAP-G (residues 479-553) by PCR-based mutagenesis. The final constructs, which encoded an N-terminally His 6 -tagged hCAP-G (residues 1-478, 554-900) and a part of hCAP-H (460-515), was used to transform Escherichia coli BL21 (DE3). Cells were grown at 37C to a cell density of about 0.8 at 660 nm in LB medium, and then cultured for a further ~20 hours at 25C after the addition of 0.2 mM isopropyl -D-1-thiogalactopyranoside (IPTG). The cells were harvested, resuspended in 10 mL of buffer I (50 mM HEPES-NaOH pH 6.8 and 250 mM NaCl) per gram of cells, and lysed by sonication. The cell lysate was clarified by centrifugation for 1 hour at 4C (48,300x g). The supernatant was applied to a 5-mL HiTrap Heparin HP column (GE Healthcare), and the bound proteins were eluted with a linear gradient of 250 to 800 mM NaCl over a total volume of 95 mL. The collected proteins were diluted with buffer II (50 mM Tris-HCl pH 8.5), and applied to a 5-mL HiTrap Q HP anion-exchange column (GE Healthcare). The bound proteins were eluted with a linear gradient of 0 to 600 mM NaCl over a total volume of 95 mL. The eluted proteins were passed through a HiLoad 16/600 Superdex 200 size-exclusion column (GE Healthcare) equilibrated with buffer III (20 mM HEPES-NaOH pH 7.4, 100 mM NaCl, and 5 mM DTT), and then concentrated to 15 mg/mL using a Vivaspin (30 kDa MWCO) concentrator (Sartorius). The purity of the hCAP-G-H subcomplex was confirmed by SDS-PAGE followed by Coomassie Brilliant Blue (CBB) staining. The purified protein was frozen with liquid N 2 and stored at -80C until use.
Crystallization, data collection, and structure determination
Crystallization of the hCAP-G-H subcomplex was performed by the sitting drop vapor-diffusion method using a commercial kit from Hampton Research, Qiagen and Molecular Dimensions to screen crystallization conditions. Drops were prepared by mixing 0.5 L of protein solution with 0.5 L of reservoir solution. Crystals were obtained in a few conditions with polyethylene glycol as a precipitant after a week at 20C. Conditions were further optimized with the hanging-drop vapor diffusion method. hCAP-G-H subcomplex crystals suitable for X-ray diffraction experiments appeared within 1 week with a reservoir solution consisting of 6.5% (w/v) PEG3350, 0.10 M MgCl 2 , 0.10 M HEPES-NaOH pH7.5, and 3% (v/v) ethylene glycol. Heavy atom derivatives of crystals were prepared by the soaking method using a solution of 1 mM Potassium dicyanoaurate (I), 7-12% (w/v) PEG3350, 0.10 M MgCl 2 , and 0.10 M HEPES-NaOH pH7.5 for 10 min. All crystals were cryoprotected with a reservoir solution including 20-25% (v/v) ethylene glycol before being flash-frozen.
Each crystal was picked up in a nylon loop, and cooled and stored in liquid N 2 gas via an Universal V1-Puck (Crystal Positioning System Inc.) until use. X-ray diffraction data of frozen crystals were collected under a stream of N 2 gas at -173C on the BL-17A beamline at Photon Factory (Tsukuba, Japan) using a pixel array photon-counting detector, PILATUS3 S6M (DECTRIS). The hCAP-G-H subcomplex crystal diffracted to 3.0 Å. Diffraction data were integrated, scaled, and averaged with program XDS (Kabsch, 2010) and SCALA (Evans, 2006) . Initial phases for the Au-labeled hCAP-G-H subcomplex was obtained by the single-wavelength anomalous dispersion (SAD) with AutoSol in the PHENIX package (Adams et al., 2010) . Model building of the hCAP-G N-terminal and C-terminal HEAT repeats and hCAP-H was done with AutoBuild in PHENIX. Subsequent model building, especially HEAT repeats of middle region of the hCAP-G was carried out with COOT (Emsley & Cowtan, 2004) , and the structure was refined with PHENIX.REFINE.
The data collection and refinement statistics were summarized in Table 1 . All structure drawings in this study were created with PyMOL (http://www.pymol.org/) and depicted a-molecule and b-molecule as a representative structure.
Interaction analysis of hCAP-G and hCAP-H co-expressed in E. coli
A cDNA encoding a central part of hCAP-H (residues 394-515) was cloned into the NdeI-XhoI site of pETDuet-1 containing the cDNA of hCAP-G (residues 1-478, 554-900) in the BamHI-HindIII site. Point mutations in the hCAP-G or hCAP-H sequence were introduced by using a PCR-based method. His 6tagged hCAP-G was co-expressed with the hCAP-H by a procedure similar to that described above, except that bacterial cells were incubated at 15C or 25C after IPTG induction. Interaction analysis, based on immobilized metal affinity chromatography (IMAC), was performed. In brief, cell lysates were applied to Ni-NTA agarose resin (Qiagen), and the beads were washed first with buffer IV (50 mM HEPES-NaOH pH 7.4, 1.5 M NaCl, and 20 mM imidazole) and then with buffer V (50 mM HEPES-NaOH pH 7.4 and 100 mM NaCl). The bound proteins were subjected to SDS-PAGE followed by CBB staining, and quantified using a ChemiDoc Touch Imaging System (Bio-Rad Laboratories).
DNA-binding assay
To obtain proteins that are used for EMSA, mutations were introduced by the same method as described above. Mutants were overexpressed and purified with Ni-NTA agarose resin. The bound protein was washed with buffer IV and buffer V, and then eluted with a stepwise gradient from 50 to 500 mM imidazole. The eluted proteins were further purified by HiTrap Q and HiLoad Superdex 200. Purified mutant proteins were concentrated, frozen with liquid N 2 , and stored at -80C until use.
To investigate the preference of the hCAP-G-H subcomplex for DNA structures, EMSA was performed using 30-mer ssDNA (5'-CCTATAGTGAGTCGTATTACAATTCACTCG-3') and 30-mer blunt-ended dsDNAs (5'-CCTATAGTGAGTCGTATTACAATTCACTCG-3'; 5'-CGAGTGAATTGTAATACGACT CACTATAGG-3'). The DNA and the subcomplex were mixed at 1:1, 1:2, and 1:4 molar ratio and incubated for overnight at 4C. Final concentration of DNA after mixing solutions was 6.7 M. These solutions were separated by electrophoresis at 4C on 1% agarose gel containing GelRed DNA stain (Biotium) and bands were detected by a ChemiDoc Touch Imaging System.
EMSA was performed at least three times and the band intensities were measured using the program ImageJ (NIH, USA). The relative band intensity was calculated by dividing the intensity of bound DNA band by the total intensity in the lane and normalized by the values of 26.8 M wild type.
Expression and purification of recombinant condensin complexes
To construct the IV-5Q mutant of hCAP-H, we used QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies) to introduce a set of point mutations sequentially into the original expression construct (pFH101; Onn et al., 2007) so that five amino-acids (F463, F469, F473, F501 and Y503) in its coding sequence were substituted with glutamine (Q). Oligonucleotides used for mutagenesis were as follows (mutation sites introduced were underlined): F469Q, 5'-GAAGATGATATTGACCAAGATGTATATTTTAGA -3'; F501Q Y503Q, 5'-CCTTCCTACAGATCAAAACCAGAATGTTGACACTCT -3'; F463Q, 5'-GATTTTGAAATTGACCAAGAAGATGATATTGAC-3'; F469Q F473Q, 5'-GACCAAGATGTATATCAAAGAAAAACAAAGGCT-3'. The resultant construct (pHM110) was used for the preparation of bacmid DNA to produce a baculovirus. Expression of condensin holocomplexes and subcomplexes in insect cells and their purification were performed as described previously (Kinoshita et al., 2015) .
Chromosome assembly assays and immunofluorescence analyses
Chromosome assembly assays using Xenopus egg extracts and immunofluorescence analyses of chromosomes assembled in the extracts were performed as described previously (Kinoshita et al., 2015) .
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